rs587777145
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001382391.1(CSPP1):c.2259_2262delAAGA(p.Glu755fs) variant causes a frameshift change. The variant allele was found at a frequency of 0.00000876 in 1,597,554 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000090 ( 0 hom. )
Consequence
CSPP1
NM_001382391.1 frameshift
NM_001382391.1 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.39
Genes affected
CSPP1 (HGNC:26193): (centrosome and spindle pole associated protein 1) This gene encodes a centrosome and spindle pole associated protein. The encoded protein plays a role in cell-cycle progression and spindle organization, regulates cytokinesis, interacts with Nephrocystin 8 and is required for cilia formation. Mutations in this gene result in primary cilia abnormalities and classical Joubert syndrome. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Apr 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 8-67158462-CAAAG-C is Pathogenic according to our data. Variant chr8-67158462-CAAAG-C is described in ClinVar as [Pathogenic]. Clinvar id is 100674.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-67158462-CAAAG-C is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CSPP1 | NM_001382391.1 | c.2259_2262delAAGA | p.Glu755fs | frameshift_variant | 20/31 | ENST00000678616.1 | NP_001369320.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CSPP1 | ENST00000678616.1 | c.2259_2262delAAGA | p.Glu755fs | frameshift_variant | 20/31 | NM_001382391.1 | ENSP00000504733.1 |
Frequencies
GnomAD3 genomes AF: 0.00000660 AC: 1AN: 151594Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
151594
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000899 AC: 13AN: 1445846Hom.: 0 AF XY: 0.0000111 AC XY: 8AN XY: 718824
GnomAD4 exome
AF:
AC:
13
AN:
1445846
Hom.:
AF XY:
AC XY:
8
AN XY:
718824
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151708Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74098
GnomAD4 genome
AF:
AC:
1
AN:
151708
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74098
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Joubert syndrome 21 Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 02, 2014 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Oct 01, 2014 | - - |
CSPP1-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 26, 2024 | The CSPP1 c.2244_2247delAAGA variant is predicted to result in a frameshift and premature protein termination (p.Glu750Lysfs*7). This variant was reported in multiple individuals with ciliopathies (Shaheen et al 2014. PubMed ID: 24360803; Alazami et al 2014. PubMed ID: 25558065, Table S1; Ben-Omran et al 2015. PubMed ID: 25997910; Shamseldin et al 2021. PubMed ID: 34645488, Table S1). This variant has not been reported in a large population database, indicating this variant is rare. Frameshift variants in CSPP1 are expected to be pathogenic. This variant is interpreted as pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 30, 2022 | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 26077850, 24360803, 25997910, 34645488) - |
Meckel-Gruber syndrome Pathogenic:1
Likely pathogenic, no assertion criteria provided | research | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Dec 01, 2014 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at